Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context
Clinical trial NCT06428838 · UNKNOWN
Trial details
- NCT number
- NCT06428838
- Sponsor
- Dr George Medvedev
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-30
- Primary completion
- 2025-12-30
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.